What tests are available to diagnose HSV (Herpes Simplex Virus) 1 and 2 in a young adult with a history of cold sores?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Testing for HSV-1 and HSV-2

Yes, multiple tests are available to diagnose HSV-1 and HSV-2, with the optimal test depending on whether you have active lesions (use PCR/NAAT) or no current symptoms (use type-specific serology). 1

When Active Lesions Are Present

PCR/NAAT testing from the lesion is the preferred diagnostic method, with >90% sensitivity and specificity. 1

  • Swab the base of the lesion and send for HSV PCR/NAAT that differentiates HSV-1 from HSV-2 1
  • As of 2019,17 FDA-approved HSV NAAT/PCR assays are available for clinical use 1
  • PCR remains highly accurate even as lesions begin healing, though sensitivity decreases as ulcers heal completely 1
  • Viral culture is an alternative if PCR is unavailable due to cost or laboratory limitations, but it is significantly less sensitive than PCR 1
  • Do not use Tzanck smear or direct immunofluorescence assay—these lack adequate sensitivity and are not recommended 1

When No Active Lesions Are Present

Type-specific HSV serology testing IgG antibodies to glycoprotein G is the appropriate test when lesions are absent. 1, 2

  • Request type-specific HSV-1 and HSV-2 IgG antibody tests using enzyme immunoassay (EIA) or chemiluminescent immunoassay (CLIA) 1, 2
  • These tests detect antibodies that develop within several weeks of infection and persist for life 2
  • Do not swab in the absence of lesions—intermittent viral shedding makes this approach insensitive 1

Critical Limitations of Serology Testing

HSV-1 Serology Issues

  • HSV-1 antibody tests have only 70.2% sensitivity, resulting in frequent false-negative results 1, 3
  • Commercial tests may miss 12-30% of true HSV-1 infections 4

HSV-2 Serology Issues

  • HSV-2 serology has serious specificity problems that depend heavily on the index value reported 1, 2, 3
  • Index values 1.1-2.9 have only 39.8% specificity (meaning 60% are false positives) 1, 2
  • Index values ≥3.0 have improved specificity of 78.6% 1, 2
  • False-positive HSV-2 results are more common in people who have HSV-1 infection, especially at low index values 1, 2, 3

Confirmation Strategy for Low-Positive Results

  • For HSV-2 results with index values between 1.1-2.9, confirm with a second test using a different glycoprotein G antigen 2, 3
  • Using the Biokit HSV-2 rapid assay as confirmation improves specificity from 93.2% to 98.7% 2, 3
  • Western blot is the gold standard but has limited availability 1, 2

Timing Considerations

  • If testing after a potential recent exposure, wait at least 12 weeks before serology testing to avoid false-negative results during the "window period" 2, 5
  • Antibodies develop within several weeks but may not be detectable immediately after infection 1, 2

Clinical Context for Your History of Cold Sores

  • Your history of cold sores indicates likely HSV-1 infection, which can be confirmed with HSV-1 IgG serology 5
  • HSV-1 can cause both oral cold sores and genital herpes through oral-genital contact 5
  • If you develop genital lesions, PCR/NAAT testing is essential to determine whether they are caused by HSV-1 or HSV-2, as this affects prognosis and counseling 1
  • HSV-2 causes more frequent genital recurrences and subclinical shedding compared to HSV-1 genital infections 2

Common Pitfalls to Avoid

  • Never accept a low-positive HSV-2 result (index 1.1-2.9) without confirmatory testing—this leads to false diagnoses with significant psychological consequences 2, 3
  • Do not use serology to diagnose active genital lesions when PCR/NAAT is available 1, 3
  • Do not test too early after exposure—wait the full 12 weeks 2, 5
  • Widespread screening of asymptomatic individuals is not recommended 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Significance of Positive HSV Type 2 IgG Antibody

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Optimal Serological Testing for Herpes Simplex Virus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Interpretation of HSV 1/2 IgG Serology Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.